Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
3 Extended Administration Pharmacokinetics in DIO Mice Neelakantan et al., Biochemical Pharmacology (2024) This study reported a 28-day once-daily administration protocol of 5-Amino-1MQ in diet-induced obese mice, characterizing plasma pharmacokinetics, tissue distribution, and effects on body composition, fatty liver pathology, and circulating biomarkers
The compound was developed by the Australian biotech firm Metabolic Pharmaceuticals as a research tool to isolate the lipolytic signaling domain of growth hormone without the receptor-binding region responsible for its anabolic and glucose-handling effects
Research Context for 5-Amino-1MQ Peptide Work involving 5-Amino-1MQ Peptide typically focuses on in vitro systems , assay development, and mechanistic model studies
These products are not for human consumption, veterinary use, or any other application involving living organisms, including but not limited to diagnostic, therapeutic, or recreational purposes
Important Information This program is provided under medical supervision only
US$ 29.29
US$ 26.36
US$ 29.32
US$ 23.88
US$ 24.35
US$ 24.59
